| Smiles |
S1(SCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C5(NC(=O)C(NC(=O)CNC(C(NC(C(NC(C(NC(C(NC(C(NC(C(NC(C(C1)NC(=O)C(NC(=O)C(N)CCCCN)CC=3(C2(=C(C=CC=C2)NC=3)))=O)CC4(=CC=CC=C4))=O)CCCNC(=N)N)=O)C(C)C)=O)CSSC5)=O)CC6(=CC=C(O)C=C6))=O)CCCNC(=N)N)=O)C(CC)C))CC7(=CC=C(O)C=C7
|
| CAS number |
118231-04-2
|
| Polar Surface Area |
1027,7
|
| calculated LogS |
-8,856
|
| Molweight |
2263,78
|
| calculated LogP |
-8,2555
|
| H-Acceptors |
54
|
| H-Donors |
37
|
| Ro5 violations |
3
|
| Druglikeness |
0,17075
|
| DrugScore |
0,196817
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Fish Toxicity |
High FHMT
|
| Fish Toxicity2 |
1,3779
|
| Rat Acute Toxicity |
2,826
|
| Acute Oral Toxicity |
III
|
| Caco-2 Permeability |
Caco2-
|
| Caco-2 Permeability2 |
-0,3482
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor |
Non-inhibitor
|
| P-glycoprotein Inhibitor2 |
Non-inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition2 |
Non-inhibitor
|
| CYP450 2C9 Substrate |
Non-substrate
|
| Tetrahymena Pyriformis Toxicity |
High TPT
|
| Tetrahymena Pyriformis Toxicity2 |
0,4651
|
| AMES Toxicity |
Non AMES toxic
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 3A4 Inhibitor |
Inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Substrate |
Non-substrate
|
| Biodegradation |
Not ready biodegradable
|
| Carcinogens |
Non-carcinogens
|
| Blood-Brain Barrier |
BBB-
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Honey Bee Toxicity |
Low HBT
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Carcinogenicity (Three-class) |
Non-required
|
| Human Intestinal Absorption |
HIA+
|
| Structure |
118231-04-2
|
